‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial shows

<p>Trial results represent ‘foundational shift’ in approach to cancer, allowing scientists to harness immune system in more personalised way</p><ul><li><p>Get our <a href="https://www.theguardian.com/email-newsletters?CMP=cvau_sfl">new political email</a>, &